Key result
Oral administration of atorvastatin for 28 days improved baroreflex sensitivity in stroke-prone spontaneously hypertensive rats.
Why the study?
Does atorvastatin improve impaired baroreflex sensitivity in stroke-prone spontaneously hypertensive rats?
Does atorvastatin improve impaired baroreflex sensitivity in stroke-prone spontaneously hypertensive rats?
Atorvastatin improves impaired baroreflex sensitivity in a hypertensive rat model via central antioxidant effects, independent of blood pressure reduction.
Answers are grounded in this paper and cite their sources.
Should not change clinical practice; hypothesis-generating for statin effects on baroreflex sensitivity in hypertensive models.
We have demonstrated that oxidative stress in the rostral ventrolateral medulla (RVLM), a vasomotor center in brainstem, increases sympathetic nerve activity (SNA) and that oral administration of atorvastatin inhibited SNA via anti-oxidant effect in the RVLM of stroke-prone spontaneously hypertensive rats (SHRSPs). The impairment of baroreflex sensitivity (BRS) is known as the predictive factor of mortality in the hypertension and BRS is impaired in SHRSP. The aim of the present study was to determine whether oral administration of atorvastatin improved the impaired BRS via anti-oxidant effect in the RVLM in SHRSP. Atorvastatin (20 mg/kg/day) or vehicle was orally administered for 28 days in SHRSPs. Systolic blood pressure (SBP), heart rate, and 24-h urinary norepinephrine excretion as an indicator of SNA were comparable between atorvastatin- and control-SHRSP. Thiobarbituric acid-reactive substance (TBARS) levels as a marker of oxidative stress was significantly lower in atorvastatin-SHRSP than in control-SHRSP. Baroreflex sensitivity measured by the spontaneous sequence method was significantly higher in atorvastatin-SHRSP than in control-SHRSP. These results suggest that atorvastatin improves the impaired BRS in SHRSP via its anti-oxidant effect in the RVLM of SHRSP.
No takes yet. Share an insight, caveat, or question.
Kishi et al. (2009) studied Hypertension. Atorvastatin vs. vehicle was evaluated on Baroreflex sensitivity. Oral administration of atorvastatin for 28 days improved baroreflex sensitivity in stroke-prone spontaneously hypertensive rats.
Synapse has enriched 10 related papers. Consider them for comparative context: